T&L Co., Ltd. (KOSDAQ:340570)

South Korea · Delayed Price · Currency is KRW

26,700

-700 (-2.55%)

Oct 12, 2026, 3:30 PM KST

Market Cap	427.19B +8.1%
Revenue (ttm)	175.16B -5.5%
Net Income	50.78B +11.2%
EPS	3,161.87 +11.8%
Shares Out	16.00M
PE Ratio	8.67
Forward PE	6.92
Dividend	750.00 (2.81%)
Ex-Dividend Date	Dec 29, 2025

Volume	73,035
Open	27,400
Previous Close	27,400
Day's Range	26,550 - 27,800
52-Week Range	21,550 - 35,800
Beta	0.34
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 13, 2026

About T&L Co., Ltd.

T&L Co., Ltd. engages in the manufacture and sale of medical and polymer material products in South Korea. Its chemical products include water borne resins, hardeners, functional additives, and urethane foam; wound care products, including hydrocolloid, foam, hydrogel, silicone, alginate, and other products; and orthopedic products, such as cast, splint, and other products. T&L Co., Ltd. was founded in 1998 and is headquartered in Yongin-si, South Korea. [Read more]

Industry Medical Devices

Sector Healthcare

Founded 1998

Employees 250

Stock Exchange KOSDAQ

Ticker Symbol 340570

Full Company Profile

Financial Performance

In 2025, T&L Co., Ltd.'s revenue was 164.16 billion, a decrease of -6.14% compared to the previous year's 174.89 billion. Earnings were 38.07 billion, a decrease of -17.96%.

Financial Statements